接受静脉溶栓治疗的急性缺血性卒中患者功能结局的时间趋势
基于奥地利卒中单元登记库2006至2019年9409例接受r-tPA治疗的患者,51.7%在卒中后3个月达到改良Rankin量表评分0至2分的良好功能结局。良好功能结局比例从2006年的45.9%升至2019年的56.8%,治疗年份与良好功能结局相关(adjOR 1.08,95%CI 1.01-1.15),交互分析提示治疗年份与卒中严重程度、以及卒中严重程度与血管内治疗之间存在正向交互作用。
要点
- 2006至2019年接受r-tPA治疗的患者良好功能结局比例从45.9%升至56.8%。
- 治疗年份与良好功能结局正相关(adjOR 1.08,95%CI 1.01-1.15)。
- 交互分析提示治疗年份与NIHSS、NIHSS与血管内治疗对功能结局存在正向交互作用。
核心结论
- 接受r-tPA治疗的患者良好功能结局比例随时间增加,可能由接受血管内治疗的更严重卒中患者结局改善所驱动,但部分亚组仍较难达到功能独立,值得特别关注。
研究设计与样本
- 分析奥地利卒中单元登记库2006至2019年接受r-tPA治疗的急性缺血性卒中患者数据。
- 良好功能结局定义为卒中后3个月改良Rankin量表评分0至2分。
- 对总体人群和预设亚组评估改良Rankin量表评分0至2分的频率,并采用多变量逻辑回归分析基线特征与结局的关联,包括临床相关交互作用。
主要发现
- 9409例接受r-tPA治疗的患者中,4865例(51.7%)在卒中后3个月达到良好功能结局。
- 2006年至2019年间,良好功能结局频率从45.9%升至56.8%。
- 多变量逻辑回归中,治疗年份与良好功能结局相关(adjOR 1.08,95%CI 1.01-1.15)。
- 卒中严重程度(NIHSS adjOR 0.86,95%CI 0.85-0.87)、年龄(61-70岁 adjOR 0.67,95%CI 0.55-0.80;71-80岁 adjOR 0.42,95%CI 0.35-0.50;>80岁 adjOR 0.16,95%CI 0.13-0.20)、女性(adjOR 0.89,95%CI 0.79-0.99)及多种合并症(如心房颤动、既往卒中、糖尿病)与良好功能结局呈负相关。
- 交互项分析提示治疗年份与NIHSS对功能结局存在正向交互作用(adjOR 1.01,95%CI 1.00-1.02),NIHSS与血管内治疗对功能结局存在正向交互作用(adjOR 1.02,95%CI 1.01-1.03)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intravenous thrombolysis improves functional outcome in patients with acute stroke and frequencies of r-tPA (recombinant tissue-type plasminogen activator) treatment have been increasing over time. We aimed to assess whether functional outcome in r-tPA-treated patients improved over time and to investigate the influence of clinical variables on functional outcome. METHODS: We analyzed data of r-tPA-treated patients in the Austrian Stroke Unit Registry from 2006 to 2019. Favorable functional outcome was defined as modified Rankin Scale score of 0 to 2. Frequencies of modified Rankin Scale score of 0 to 2 were assessed for the overall population and in prespecified subgroups; multivariable logistic regression analysis was performed to assess associations of baseline characteristics including clinically relevant interactions, and outcome. RESULTS: Overall, 4865 out of 9409 r-tPA-treated patients (51.7%) achieved favorable functional outcome 3 months post stroke. Between 2006 and 2019, frequencies of favorable functional outcome increased from 45.9% to 56.8%. In multivariable logistic regression analysis, year of treatment (adjusted odds ratio [adjOR], 1.08 [95% CI, 1.01-1.15]) was associated with favorable functional outcome. Stroke severity (National Institutes of Health Stroke Scale, adjOR, 0.86 [95% CI, 0.85-0.87]), age (61-70 years: adjOR, 0.67 [95% CI, 0.55-0.80], 71-80 years: adjOR, 0.42 [95% CI, 0.35-0.50], >80 years: adjOR, 0.16 [95% CI, 0.13-0.20]), female sex (adjOR, 0.89 [95% CI, 0.79-0.99]), and various comorbidities (eg, atrial fibrillation, prior stroke, diabetes) were negatively associated. Inclusion of interaction terms into the multivariable logistic regression model suggests a positive effect of year of treatment and endovascular treatment by increasing stroke severity on functional outcome (interaction between year of treatment and National Institutes of Health Stroke Scale: adjOR, 1.01 [95% CI, 1.00-1.02], interaction between National Institutes of Health Stroke Scale and endovascular treatment: adjOR, 1.02 [95% CI, 1.01-1.03]). CONCLUSIONS: Frequencies of favorable functional outcome in r-tPA-treated patients have been increasing over time, likely driven by improved outcome in patients with more severe strokes receiving endovascular treatment. However, some subgroups are still less likely to achieve functional independency and deserve particular attention.
引用
- Marko M, Miksova D, Ebner J, et al. Temporal Trends of Functional Outcome in Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis. Stroke. 2022. PMID: 36000395. doi:10.1161/STROKEAHA.121.038400
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。